Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 859 of 1,261
  1. US 8501953

    PKM2 modulators for use in the treatment of cancer

    Agios Pharmaceuticals, Inc. · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  2. US 8501750

    Heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  3. US 8501681

    Macrocyclic hepatitis C virus serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  4. US 8501682

    Difluorinated tripeptides as HCV serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  5. US 8501692

    Compositions and methods for altering cocaine esterase activity

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  6. US 8501705

    Methods and materials for treating autoimmune and/or complement mediated diseases and conditions

    The Board of Regents of the University of Texas System · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  7. US 8501695

    Tissue kallikrein for the treatment of diseases associated with amyloid protein

    DiaMedica Inc. · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  8. US 8501688

    SCGB3A2 as a growth factor and anti-apoptotic agent

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  9. US 8501704

    Immunosuppression compound and treatment method

    Sarepta Therapeutics, Inc. · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  10. US 8501713

    Drug combinations for the treatment of duchenne muscular dystrophy

    Summit Corporation Plc · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  11. US 8501727

    Short acting benzothiazepine calcium channel blockers and uses thereof

    Milestone Pharmaceuticals Inc. · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  12. US 8501740

    Methods of treatment of opioid tolerance, physical dependence, pain and addiction with inhibitors of certain growth factor receptors

    The Board of Regents of the University of Texas System · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  13. US 8501746

    Organic compounds

    Xenon Pharmaceuticals Inc. · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  14. US 8501803

    Garcinia derivative, its preparing method and medicinal use

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  15. US 8501899

    Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same

    Serina Therapeutics, Inc. · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  16. US 8501912

    Filipil compositions and methods for treating cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  17. US 8501905

    Synthetic cell platforms and methods of use thereof

    The Regents of the University of California · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  18. US 8501783

    Conformationally restricted urea inhibitors of soluble epoxide hydrolase

    The Regents of the University of California · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  19. US 8501184

    High affinity human antibodies to PCSK9

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  20. US 8501247

    Pest control using natural pest control agent blends

    TYRATECH, INC. · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  21. US 8501722

    Methods and compositions for treating bacterial infection

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  22. US 8501188

    Method of treating inflammatory lung disease with suppressors of CpG oligonucleotides

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  23. US 8501191

    FGFR2-IIIb fusion proteins and methods of making them

    Five Prime Therapeutics, Inc. · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  24. US 8501229

    Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings

    ATRIUM MEDICAL CORPORATION · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.